Evidence map›Paper›PMID 40489068›Full record

ArticleChemistryOpen2025

Exploring Unspecific Peroxygenase Selectivity with Diverse Hydrocarbon Substrates.

Essi Rytkönen, Nina Hakulinen, Janne Jänis, Juha Rouvinen

Abstract read
In one paragraph

Article in ChemistryOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Essi RytkönenDepartment of Chemistry, University of Eastern Finland, P.O. Box 111, FI-80101, Joensuu, Finland.ORCID https://orcid.org/0000-0002-9549-6373
Nina HakulinenDepartment of Chemistry, University of Eastern Finland, P.O. Box 111, FI-80101, Joensuu, Finland.ORCID https://orcid.org/0000-0003-4471-7188
Janne JänisDepartment of Chemistry, University of Eastern Finland, P.O. Box 111, FI-80101, Joensuu, Finland.ORCID https://orcid.org/0000-0002-8446-4704
Juha RouvinenDepartment of Chemistry, University of Eastern Finland, P.O. Box 111, FI-80101, Joensuu, Finland.ORCID https://orcid.org/0000-0003-1843-5718

Funding

Research Council of Finland 321503/ActiveCH and 355455/Oxyfunc
6 · The paper itself

Abstract

Unspecific peroxygenases (UPOs) are enzymes capable of oxidising various substrates using hydrogen peroxide as a co-substrate. UPOs have gained interest due to their broad substrate specificity, which includes relatively inexpensive precursors for valuable compounds, such as pharmaceuticals and chemical building blocks. In this study, the activity of a panel of 30 UPOs toward aliphatic and aromatic hydrocarbons was screened to assess variation in substrate selectivity. Most of the studied UPOs were able to oxidise the substrates efficiently, producing 2-5 products via hydrogen abstraction or epoxidation. Overall trends were observed, such as the preference for aromatic oxidation over benzylic hydroxylation in the case of toluene, while the opposite was observed with ethylbenzene. Different UPOs could also be categorized based on their reaction profiles with all substrates. Selectivity was generally low, as oxyfunctionalization reactions led to mixtures of products that were further oxidised. However, styrene and cyclohexene were converted rather exclusively to their epoxide products. The results indicate that the substrate scope of UPOs includes various types of hydrocarbons, which are oxidised depending on the individual enzyme's active site. They also hold potential for producing chemicals for industrial purposes more sustainably, but their selectivity should first be improved through protein engineering.

Indexed as

HydrocarbonsHydroxylationOxyfunctionalizationSelectivityUnspecific peroxygenase

Identifiers

PMID40489068
PMCPMC12598796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.